[1]
S. Podder, M. Masudur Rahman, M. I. Hossain, R. Datta, J. Alam, and M. Golam Kibria, “Efficacy of rifaximin among non-constipated irritable bowel syndrome patients with or without small intestinal bacterial overgrowth: a randomized, double-blind, placebo-controlled trial”, Int J Res Med Sci, vol. 12, no. 4, pp. 1056–1064, Mar. 2024.